Steve Trokenheim and Dan Schulman on how to sustain commercial operations during a pandemic

Share on facebook
Share on twitter
Share on linkedin

The coronavirus presents several challenges for life sciences manufacturers – and how they respond will define them for years to come. Partner Steve Trokenheim and Associate Partner Dan Schulman describe in Pharmaceutical Executive how a measured approach to commercial operations can help navigate uncertainty and set up companies for long-term success.